CD59a is the primary regulator of membrane attack complex assembly in the mouse

被引:67
作者
Baalasubramanian, S
Harris, CL
Donev, RM
Mizuno, M
Omidvar, N
Song, WC
Morgan, BP [1 ]
机构
[1] Cardiff Univ, Coll Med, Dept Med Biochem & Immunol, Complement Biol Grp, Cardiff CF14 4XN, S Glam, Wales
[2] Univ Penn, Sch Med, Ctr Expt Therapeut, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
D O I
10.4049/jimmunol.173.6.3684
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Gene-deleted mice have provided a potent tool in efforts to understand the roles of complement and complement-regulating proteins in vivo. In particular, mice deficient in the membrane regulators complement receptor 1-related gene/protein y, decay-accelerating factor, or CD59 have demonstrated homeostatic relevance and backcrossing between the strains has revealed cooperativity in regulation. In mouse, genes encoding decay-accelerating factor and CD59 have been duplicated and show differential expression in tissues, complicating interpretation and extrapolation of findings to man. The first described form of CD59, CD59a, is broadly distributed and deletion of the cd59a gene causes a mild hemolytic phenotype with increased susceptibility in complement-mediated disease models. The distribution of the second form, CD59b, was originally described as testis specific, but later by some as widespread. Deletion of the cd59b gene caused a severe hemolytic and thrombotic phenotype. To apply data from these mouse models to man it is essential to know the relative distribution and functional roles of these two forms of CD59. We have generated new specific reagents and used them in sensitive quantitative analyses to comprehensively characterize expression of mRNA and protein and functional roles of CD59a and CD59b in wild-type (wt) and CD59a-negative mice. cd59b mRNA was detected only in testis and, at very low levels, in bone marrow. CD59b protein was present on mature spermatozoa and precursors and, in trace amounts, erythrocytes. Erythrocyte CD59b did not inhibit complement lysis except when CD59a was absent or blocked. These data confirm that CD59a is the primary regulator of complement membrane attack in mouse.
引用
收藏
页码:3684 / 3692
页数:9
相关论文
共 33 条
  • [1] *ABI PRISM 7700 SE, 1997, ABI PRISM 7700 SEQ D, V2
  • [2] Molecular basis for a link between complement and the vascular complications of diabetes
    Acosta, J
    Hettinga, J
    Flückiger, R
    Krumrei, N
    Goldfine, A
    Angarita, L
    Halperin, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) : 5450 - 5455
  • [3] Cochrane C G, 1973, Adv Immunol, V16, P185, DOI 10.1016/S0065-2776(08)60298-9
  • [4] MEMBRANE DEFENSE AGAINST COMPLEMENT LYSIS - THE STRUCTURE AND BIOLOGICAL PROPERTIES OF CD59
    DAVIES, A
    LACHMANN, PJ
    [J]. IMMUNOLOGIC RESEARCH, 1993, 12 (03) : 258 - 275
  • [5] Davis KA, 1997, United States Patent, Patent No. 5620842
  • [6] Gamier G., 2003, BIOCHEM J, V371, P631
  • [7] Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison
    Harris, CL
    Hanna, SM
    Mizuno, M
    Holt, DS
    Marchbank, KJ
    Morgan, BP
    [J]. IMMUNOLOGY, 2003, 109 (01) : 117 - 126
  • [8] Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria
    Holt, DS
    Botto, M
    Bygrave, AE
    Hanna, SM
    Walport, MJ
    Morgan, BP
    [J]. BLOOD, 2001, 98 (02) : 442 - 449
  • [9] Iyer SB., 1997, QUANTIBRITE NEW STAN
  • [10] MOUSE COMPLEMENT REGULATORY PROTEIN CRRY/P65 USES THE SPECIFIC MECHANISMS OF BOTH HUMAN DECAY-ACCELERATING FACTOR AND MEMBRANE COFACTOR PROTEIN
    KIM, YU
    KINOSHITA, T
    MOLINA, H
    HOURCADE, D
    SEYA, T
    WAGNER, LM
    HOLERS, VM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) : 151 - 159